Literature DB >> 22579526

Disruption of Purkinje cell function prior to huntingtin accumulation and cell loss in an animal model of Huntington disease.

S E Dougherty1, J L Reeves, E K Lucas, K L Gamble, M Lesort, R M Cowell.   

Abstract

Huntington Disease (HD) is a devastating neurological disorder characterized by progressive deterioration of psychiatric, motor, and cognitive function. Purkinje cells (PCs), the output neurons of the cerebellar cortex, have been found to be vulnerable in multiple CAG repeat disorders, but little is known about the involvement of PC dysfunction in HD. To investigate possible PC abnormalities, we performed quantitative real time PCR, Western blot analysis, and immunohistochemistry experiments to explore the changes in PC markers in the R6/2 mouse model of severe HD. There were reductions in the transcript and protein levels of the calcium-binding proteins parvalbumin and calbindin, as well as the enzyme glutamic acid decarboxylase 67. Immunohistochemistry supported these results, with the most substantial changes occurring in the PC layer. To determine whether the reductions in PC marker expression were due to cell loss, we performed stereology on both presymptomatic and end-stage R6/2 mice. Stereological counts indicated a significant reduction in PC number by end-stage but no change in presymptomatic animals (4 weeks of age). To assess cellular function prior to cell loss and symptom onset, we measured spontaneous firing in PCs from 4-week old animals and found a striking deficit in PC firing as indicated by a 57% decrease in spike rate. Interestingly, huntingtin inclusions were not widely observed in PCs until 12 weeks of age, indicating that soluble huntingtin and/or abnormalities in other cell types may contribute to PC dysfunction. Considering the roles for PCs in motor control, these data suggest that early PC dysfunction potentially contributes to motor impairment in this model of HD.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22579526      PMCID: PMC3367067          DOI: 10.1016/j.expneurol.2012.04.015

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  57 in total

1.  Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice.

Authors:  G J Klapstein; R S Fisher; H Zanjani; C Cepeda; E S Jokel; M F Chesselet; M S Levine
Journal:  J Neurophysiol       Date:  2001-12       Impact factor: 2.714

2.  Huntington aggregates may not predict neuronal death in Huntington's disease.

Authors:  S Kuemmerle; C A Gutekunst; A M Klein; X J Li; S H Li; M F Beal; S M Hersch; R J Ferrante
Journal:  Ann Neurol       Date:  1999-12       Impact factor: 10.422

3.  Evaluation of R6/2 HD transgenic mice for therapeutic studies in Huntington's disease: behavioral testing and impact of diabetes mellitus.

Authors:  H G Lüesse; J Schiefer; A Spruenken; C Puls; F Block; C M Kosinski
Journal:  Behav Brain Res       Date:  2001-11-29       Impact factor: 3.332

4.  Abnormalities in the synaptic vesicle fusion machinery in Huntington's disease.

Authors:  A J Morton; R L Faull; J M Edwardson
Journal:  Brain Res Bull       Date:  2001-09-15       Impact factor: 4.077

5.  Huntingtin aggregation kinetics and their pathological role in a Drosophila Huntington's disease model.

Authors:  Kurt R Weiss; Yoko Kimura; Wyan-Ching Mimi Lee; J Troy Littleton
Journal:  Genetics       Date:  2011-11-17       Impact factor: 4.562

6.  Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain.

Authors:  Ruth Luthi-Carter; Sarah A Hanson; Andrew D Strand; Donald A Bergstrom; Wanjoo Chun; Nikki L Peters; Annette M Woods; Edmond Y Chan; Charles Kooperberg; Dimitri Krainc; Anne B Young; Stephen J Tapscott; James M Olson
Journal:  Hum Mol Genet       Date:  2002-08-15       Impact factor: 6.150

7.  Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis.

Authors:  H D Rosas; W J Koroshetz; Y I Chen; C Skeuse; M Vangel; M E Cudkowicz; K Caplan; K Marek; L J Seidman; N Makris; B G Jenkins; J M Goldstein
Journal:  Neurology       Date:  2003-05-27       Impact factor: 9.910

8.  Polyglutamine-expanded ataxin-7 promotes non-cell-autonomous purkinje cell degeneration and displays proteolytic cleavage in ataxic transgenic mice.

Authors:  Gwenn A Garden; Randell T Libby; Ying-Hui Fu; Yoshito Kinoshita; Jing Huang; Daniel E Possin; Annette C Smith; Refugio A Martinez; Gabriel C Fine; Sara K Grote; Carol B Ware; David D Einum; Richard S Morrison; Louis J Ptacek; Bryce L Sopher; Albert R La Spada
Journal:  J Neurosci       Date:  2002-06-15       Impact factor: 6.167

Review 9.  'New' functions for 'old' proteins: the role of the calcium-binding proteins calbindin D-28k, calretinin and parvalbumin, in cerebellar physiology. Studies with knockout mice.

Authors:  Beat Schwaller; Michael Meyer; Serge Schiffmann
Journal:  Cerebellum       Date:  2002-12       Impact factor: 3.847

Review 10.  [A case of adult-onset Huntington disease presenting with spasticity and cerebellar ataxia, mimicking spinocerebellar degeneration].

Authors:  Yasufumi Kageyama; Shinji Yamamoto; Masao Ueno; Keiji Ichikawa
Journal:  Rinsho Shinkeigaku       Date:  2003 Jan-Feb
View more
  16 in total

Review 1.  The role for alterations in neuronal activity in the pathogenesis of polyglutamine repeat disorders.

Authors:  Ravi Chopra; Vikram G Shakkottai
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

2.  Knockdown of acid-sensing ion channel 1a (ASIC1a) suppresses disease phenotype in SCA1 mouse model.

Authors:  Parminder J S Vig; Scoty M Hearst; Qingmei Shao; Maripar E Lopez
Journal:  Cerebellum       Date:  2014-08       Impact factor: 3.847

3.  Transient cerebellar alterations during development prior to obvious motor phenotype in a mouse model of spinocerebellar ataxia type 6.

Authors:  Sriram Jayabal; Lovisa Ljungberg; Alanna J Watt
Journal:  J Physiol       Date:  2016-10-02       Impact factor: 5.182

4.  Unusually slow spike frequency adaptation in deep cerebellar nuclei neurons preserves linear transformations on the sub-second timescale.

Authors:  Mehak M Khan; Shuting Wu; Christopher H Chen; Wade G Regehr
Journal:  J Neurosci       Date:  2022-08-19       Impact factor: 6.709

Review 5.  Channelopathy of small- and intermediate-conductance Ca2+-activated K+ channels.

Authors:  Young-Woo Nam; Myles Downey; Mohammad Asikur Rahman; Meng Cui; Miao Zhang
Journal:  Acta Pharmacol Sin       Date:  2022-06-17       Impact factor: 7.169

Review 6.  Electrophysiological Studies Support Utility of Positive Modulators of SK Channels for the Treatment of Spinocerebellar Ataxia Type 2.

Authors:  Polina A Egorova; Ilya B Bezprozvanny
Journal:  Cerebellum       Date:  2022-01-03       Impact factor: 3.648

7.  Rapid generation of sub-type, region-specific neurons and neural networks from human pluripotent stem cell-derived neurospheres.

Authors:  Aynun N Begum; Caleigh Guoynes; Jane Cho; Jijun Hao; Kabirullah Lutfy; Yiling Hong
Journal:  Stem Cell Res       Date:  2015-10-24       Impact factor: 2.020

8.  Translating cerebellar Purkinje neuron physiology to progress in dominantly inherited ataxia.

Authors:  Ravi Chopra; Vikram G Shakkottai
Journal:  Future Neurol       Date:  2014-03-01

9.  Purkinje cell dysfunction and loss in a knock-in mouse model of Huntington disease.

Authors:  S E Dougherty; J L Reeves; M Lesort; P J Detloff; R M Cowell
Journal:  Exp Neurol       Date:  2012-11-26       Impact factor: 5.330

10.  In vivo analysis of the spontaneous firing of cerebellar Purkinje cells in awake transgenic mice that model spinocerebellar ataxia type 2.

Authors:  Polina A Egorova; Aleksandra V Gavrilova; Ilya B Bezprozvanny
Journal:  Cell Calcium       Date:  2020-11-16       Impact factor: 6.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.